eMove - Dance/Movement Therapy Study | Clinical Trial | StuddyBuddy@endsection eMove - Dance/Movement Therapy Study
Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05712928

eMove - Dance/Movement Therapy Study

Conditions: Schizophrenia, Schizoaffective Disorder

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 10
Sponsor: Drexel University

Location: United States

Summary

Schizophrenia is a chronic and severe mental disorder affecting 20 million people throughout the world and is the fourth leading cause of disability in the developed world. Currently, restrictions due to the COVID-19 pandemic, cause greater social withdrawal, reduced access to social support, lack of motivation, under-activity and loneliness for patients with schizophrenia. Given the prevalence of under-activity, interventions such as dance/movement therapy that use movement and dance to support intellectual, emotional, and motor functions of the body, can optimize the functioning of individuals with schizophrenia. There have been urgent calls for research on telehealth interventions to address the mental health needs caused by COVID-19 pandemic. To address this call, this study will test the feasibility and acceptability of a novel, 10-week dance/movement therapy protocol to promote activation in chronic schizophrenia designed for telehealth delivery. This study will be the first to examine the feasibility and preliminary effects of telehealth dance/movement therapy to promote activation in chronic schizophrenia. This study can contribute towards the development of telehealth interventions for treatment and rehabilitation of individuals with chronic schizophrenia.

Eligibility Criteria

Inclusion Criteria:18 years of age or older,Schizophrenia or schizoaffective disorder diagnosis,Able to speak and write English,Able to attend sessions via Zoom (including internet connection and a device with camera).Exclusion Criteria:An organic brain disease or substance abuse as the primary diagnosis,A diagnosis of dementia or cognitive impairment that would interfere with competence to consent to participation.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05712928). StuddyBuddy aggregates publicly available trial information.